Gabapentin in Patients at Clinical Risk for Psychosis

NCT02557945 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Combination of insufficient funding and lack of compelling findings

Conditions

Clinical High Risk for Psychosis

Interventions

DRUG: Gabapentin
DRUG: Placebo

Sponsor

New York State Psychiatric Institute